Cassava Sciences, Inc. ( SAVA) - Stock Earnings
Stock symbol SAVA is outdated, potentially delisted? Maybe it is available on other exchange?
Ticker SAVA was renamed to
FLNA
effective 2026-03-11.
SAVA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -26.4 million USD | — USD |
| 2023Q3 | -25.7 million USD | — USD |
| 2023Q4 | -20.9 million USD | 2.3 million USD |
SAVA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -31.8 million USD | 0 USD |
| 2022 | -72.5 million USD | -1800 USD |
| 2023 | -97.2 million USD | — USD |
SAVA
Price: $2.38
52 week price:
Earnings Per Share: -2.22 USD
P/E Ratio: -0.91
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2.0 million
Market Capitalization: 98.1 million